Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: DECLARATION OF HAROLD H. DAVIS IN SUPPORT OF PLAINTIFFS’ REPLY TO STAY ALL PROCE

< In response to the rejection of claims 29-54 of United States Patent No. 5,784,584, Defendants initially agreed, in writing, that they intended to withdraw the ‘584 patent from this action, subject to agreement on the form of dismissal. However, Defendants subsequently reconsidered their position and have stated that they no longer intend to dismiss the ‘584 patent from this case.>

And we all know why.

<On March 17, 2009, about six weeks after this Court denied reconsideration of Defendants’ Motion to Dismiss, the USPTO issued a final rejection of the asserted claims of the 336 patent. Plaintiffs proposed that the ‘336 patent also be withdrawn from this case, but on April 17, 2009, Defendants declined to do so. >

That was after the meeting with the examiner on April 9th. Best news I've head in awhile. Thank you Harold H. Davis.

Opty

Share
New Message
Please login to post a reply